Physician profile
Victor Adkisson
NPI 1912058553
$2,774.41
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $361 · 2021: $1,197 · 2022: $177 · 2023: $48.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $647.53 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $306.77 | 2019-2022 | |
| Pfizer INC. | $275.24 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $261.50 | 2019-2022 | |
| Abbvie INC. | $233.50 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $191.08 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.97 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $152.87 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $101.25 | 2019 | |
| Allergan, INC. | $95.37 | 2019-2020 | |
| Gilead Sciences, INC. | $81.40 | 2021-2023 | Veklury |
| Sunovion Pharmaceuticals INC. | $77.49 | 2019 | |
| Alexion Pharmaceuticals, INC. | $40.68 | 2019-2021 | |
| Boston Scientific Corporation | $40.39 | 2019-2021 | |
| Cmp Pharma, INC. | $22.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $17.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.35 | 2020 | |
| Shire North American Group INC | $13.60 | 2019 | |
| Philips North America LLC | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Adkisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.